American pharmaceutical giant Johnson & Johnson has submitted an application to the Ministry of Health, Labor and Welfare for approval of the new coronavirus vaccine.
"Johnson & Johnson" announced on the 24th that it has applied for approval to the Ministry of Health, Labor and Welfare through a group company for the new coronavirus vaccine that it has developed.
This is the fourth domestic approval application following the Pfizer, AstraZeneca, and Moderna vaccines.
The feature is that only one inoculation is required, and the target is 20 years old or older.
In the interim report of overseas clinical trials, 66% was confirmed to be effective in preventing moderate symptoms and severe illness, and 85% in severe cases.
In addition, as a result of the interim analysis, no new safety risk was found in the data of domestic clinical trials conducted on about 250 Japanese people over 20 years old.
"Johnson & Johnson" has not signed a contract with the Japanese government to supply vaccines, but if approved, it may be able to supply it to Japan early next year.
This vaccine has already been inoculated in Europe and the United States, and the inoculation was suspended because a rare thrombosis was reported in the United States. I will.
Chief Cabinet Secretary Kato "It is desirable to have more choices"
At a press conference in the afternoon, Chief Cabinet Secretary Kato said, "I am aware that the examination will proceed promptly with the highest priority given to confirmation of efficacy and safety. In Japan, Pfizer, Moderna, and AstraZeneca have already been examined. Three of the company's new corona vaccines have been regulatoryly approved, but we hope that more vaccine options will be available. In any case, we would like to wait for the results of the approval review. " ..